Findings

What do systematic reviews say?

1,290 questions · 1,309 findings · 571 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1,309 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

VAL‐1221 vs alglucosidase alfa

Treatment‐related adverse events · adults with LOPD

The review found no eligible studies for this question.

1 finding from 1 review

Enzyme replacement therapy for late‐onset Pompe disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Prefabricated foot orthoses vs shoes

Withdrawals due to adverse events · children with symptomatic flat feet

The review found no eligible studies for this question.

1 finding from 1 review

Foot orthoses for treating paediatric flat feet 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Hydromorphone vs fentanyl

Nausea · people with moderate to severe cancer pain

The review found no eligible studies for this question.

1 finding from 1 review

Hydromorphone for cancer pain 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Casirivimab/imdevimab vs usual care

Serious adverse events by day 30 · hospitalised individuals with COVID‐19 (moderate to severe disease)

The review found no eligible studies for this question.

1 finding from 1 review

SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Probiotic + 5‐aminosalicylic acid (5‐ASA) (mesalazine) vs 5‐aminosalicylic acid (5‐ASA) (mesalazine)

Withdrawals due to adverse events · people with active UC

The review found no eligible studies for this question.

1 finding from 1 review

Probiotics for induction of remission in ulcerative colitis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

CBT with therapist support vs fatigue information leaflet only

Withdrawals due to adverse events · IBD patients

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for fatigue in inflammatory bowel disease 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Physical activity advice plus omega 3 vs no physical activity advice plus omega 3

Withdrawals due to adverse events · participants with quiescent IBD

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for fatigue in inflammatory bowel disease 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Adalimumab vs active comparators

Withdrawals due to adverse events · People with quiescent Crohn's disease (ileocolic resection)

The review found no eligible studies for this question.

1 finding from 1 review

Adalimumab for maintenance of remission in Crohn's disease 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Zinc tape vs magnesium sulphate glycerin

Priimary outcome: adverse events · ulceration caused by nerve damage in leprosy

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for ulceration and other skin changes caused by nerve damage in leprosy 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Enteral nutrition vs 6‐MP

Withdrawals due to adverse events · Participants with Crohn's disease in remission

The review found no eligible studies for this question.

1 finding from 1 review

Enteral nutrition for maintenance of remission in Crohn's disease 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Enteral nutrition vs mesalamine

Withdrawals due to adverse events · Participants with Crohn's disease in remission

The review found no eligible studies for this question.

1 finding from 1 review

Enteral nutrition for maintenance of remission in Crohn's disease 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cannabis oil (5% cannabidiol sublingual oil) vs placebo oil

Withdrawals due to adverse events · Patients with active Crohn's disease

The review found no eligible studies for this question.

1 finding from 1 review

Cannabis for the treatment of Crohn's disease 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cannabis oil (15% cannabidiol and 4% THC) vs placebo oil

Withdrawals due to adverse events · Patients with active Crohn's disease

The review found no eligible studies for this question.

1 finding from 1 review

Cannabis for the treatment of Crohn's disease 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cannabis cigarettes (115 mg THC) vs placebo cigarettes

Withdrawals due to adverse events · Patients with active Crohn's disease

The review found no eligible studies for this question.

1 finding from 1 review

Cannabis for the treatment of Crohn's disease 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cannabis cigarettes vs placebo

Withdrawals due to adverse events · people with active UC

The review found no eligible studies for this question.

1 finding from 1 review

Cannabis for the treatment of ulcerative colitis 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Capsaicin vs placebo

Treatment‐related adverse events · non‐allergic rhinitis

The review found no eligible studies for this question.

1 finding from 1 review

Capsaicin for non‐allergic rhinitis 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Capsaicin vs budesonide

Treatment‐related adverse events · patients with non‐allergic rhinitis

The review found no eligible studies for this question.

1 finding from 1 review

Capsaicin for non‐allergic rhinitis 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Five capsaicin treatments in one day vs daily capsaicin treatment

Treatment‐related adverse events · patients with non‐allergic rhinitis

The review found no eligible studies for this question.

1 finding from 1 review

Capsaicin for non‐allergic rhinitis 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Oral NSAIDs vs placebo

Withdrawals due to adverse events · Adults with lateral elbow pain

The review found no eligible studies for this question.

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs (NSAIDs) for treating lateral elbow pain in adults 2013 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Oral NSAIDs vs glucocorticoid injection

Withdrawals due to adverse events · Adults with lateral elbow pain

The review found no eligible studies for this question.

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs (NSAIDs) for treating lateral elbow pain in adults 2013 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found